Government
Senate Committee Holds Hearing on Cannabis Decriminalization Bill
The Senate Judiciary Subcommittee on Crime and Terrorism held a hearing on Tuesday to discuss the Cannabis Administration and Opportunity Act, a bill introduced last week that would federally decriminalize marijuana.
A Senate panel met on Tuesday to consider a bill that would decriminalize cannabis at the federal level, less than a week after the legislation was introduced by Senate Majority Leader Chuck Schumer and two Democratic colleagues. The bill, the Cannabis Administration and Opportunity Act, was introduced on July 21 by Schumer, the senior senator from New York, Senate Finance Chair Ron Wyden of Oregon and New Jersey’s Senator Cory Booker.
The Senate Judiciary Subcommittee on Crime and Terrorism, which is chaired by Booker, discussed the legislation and heard testimony from witnesses at a hearing held at the nation’s Capitol on Tuesday. Under the nearly 300 pages of legislation, marijuana would be removed from regulation under the federal Controlled Substances Act, where the drug is listed under the most restrictive Schedule I, and states would be allowed to create their own cannabis policies. The measure would also establish a national tax on cannabis products, expunge records of past federal cannabis convictions, and allow nonviolent cannabis prisoners to request resentencing.
Booker, the chair of the subcommittee and the only Black senator on the Senate Judiciary Committee, said that national cannabis prohibition has “miserably failed” and has led to a “festering injustice” of enforcement policy that disproportionately targets Black and Brown communities. According to a 2020 report from the American Civil Liberties Union, Black people in America are almost four times more likely to be arrested for a cannabis-related offense than whites, despite relatively equal rates of pot use.
“Cannabis laws are unevenly enforced and devastate the lives of those most vulnerable,” Booker said during the Tuesday hearing.
Witnesses Testify To Support Cannabis Decriminalization Bill
Weldon Angelos, a former federal cannabis prisoner and criminal justice reform advocate, appeared before the subcommittee to testify in favor of the legislation. Sentenced to 55 years in federal prison for a first-time cannabis conviction and firearms possession charge, Angelos spent 13 years behind bars before being released in 2016. He told the senators at the hearing that expungement is a vital element of cannabis policy reform.
“Each arrest, prosecution, conviction and sentence makes the world a little bit smaller for those bearing the modern scarlet letter,” Angelos said, referring to what life is like for those with a conviction for a drug offense.
Representatives of the law enforcement community also testified in favor of the legislation to reform the nation’s marijuana laws. Edward Jackson, chief of the Annapolis Police Department, told the subcommittee that “there is nothing inherently violent” about cannabis.
Jackson said that decriminalization would permit police officers to concentrate on more serious crimes and help restore the community’s trust in law enforcement.
“I have spent far too much time arresting people for selling and possessing cannabis,” Jackson testified.
Senator Tom Cotton, a Republican from Missouri, lodged his opposition to the cannabis legalization bill and expungement, arguing that the legislation “would wipe clean the criminal records of illegal alien traffickers.”
“When these criminals trafficked marijuana, they broke the law,” Cotton told his colleagues on the subcommittee. “Whether some find that law unfashionable or even unfair, what they did was illegal.”
Cannabis Industry Reacts to Senate Hearing
Mason Tvert, partner at cannabis policy consulting firm VS Strategies, told High Times after Tuesday’s hearing that it “is refreshing to finally see a significant discussion of cannabis policy in Congress’ upper chamber.”
“History has shown that the more people talk about and hear about cannabis, the more quickly support grows for ending its prohibition,” Tvert wrote in an email. “Hopefully there will be more to follow, and members will have an opportunity to continue hearing about the many important aspects of this major policy issue, from expungement and equity to the economics and public safety benefits of legalization.”
Ryan G. Smith, co-founder and CEO of online cannabis wholesale platform LeafLink, urged lawmakers to approve comprehensive cannabis policy reform at the national level.
“For far too long, communities of color have been disproportionately harmed by unjust cannabis laws,” Smith wrote in an email to High Times. “Today’s hearing was a step forward, but now it’s time for Congress to take real action to end prohibition and support communities that have been unfairly targeted and left behind.”
But George Mancheril, co-founder and CEO of cannabis industry lender Bespoke Financial, is not optimistic that meaningful cannabis policy reform measures will be approved in the near future, noting that less controversial bills such as the Secure and Fair Enforcement (SAFE) Banking Act, which would allow banks to offer financial services to legal cannabis companies, have not fared well in the upper chamber of Congress.
“This hearing was an important step towards federal cannabis legalization but illustrated the long road still ahead. Passing comprehensive legislation is significantly harder than limited scope proposals such as the SAFE Banking Act which stalled in the Senate numerous times,” Mancheril said in an email. “The current political and economic environment will likely continue to keep all such cannabis focused bills on the fringe of political discussion and unlikely to pass any time soon but we hope that future hearings will drive the discussion towards the mechanics and timeline for federal regulation to provide greater clarity and transparency to the industry and to all stakeholders.”
Source: https://hightimes.com/news/senate-committee-holds-hearing-on-cannabis-decriminalization-bill/
New Mexico regulators fined a cannabis operator nearly $300,000 and revoked its license after the company allegedly created fake reports in the state’s traceability software.
The New Mexico Cannabis Control Division (CCD) accused marijuana manufacturer and retailer Golden Roots of 11 violations, according to Albuquerque Business First.
Golden Roots operates the The Cannabis Revolution Dispensary.
The majority of the violations are related to the Albuquerque company’s improper use of BioTrack, which has been New Mexico’s track-and-trace vendor since 2015.
The CCD alleges Golden Roots reported marijuana production only two months after it had received its vertically integrated license, according to Albuquerque Business First.
Because cannabis takes longer than two months to be cultivated, the CCD was suspicious of the report.
After inspecting the company’s premises, the CCD alleged Golden Roots reported cultivation, transportation and sales in BioTrack but wasn’t able to provide officers who inspected the site evidence that the operator was cultivating cannabis.
In April, the CCD revoked Golden Roots’ license and issued a $10,000 fine, according to the news outlet.
The company requested a hearing, which the regulator scheduled for Sept. 1.
At the hearing, the CCD testified that the company’s dried-cannabis weights in BioTrack were suspicious because they didn’t seem to accurately reflect how much weight marijuana loses as it dries.
Company employees also poorly accounted for why they were making adjustments in the system of up to 24 pounds of cannabis, making comments such as “bad” or “mistake” in the software, Albuquerque Business First reported.
Golden Roots was fined $298,972.05 – the amount regulators allege the company made selling products that weren’t properly accounted for in BioTrack.
The CCD has been cracking down on cannabis operators accused of selling products procured from out-of-state or not grown legally:
- Regulators alleged in August that Albuquerque dispensary Sawmill Sweet Leaf sold out-of-state products and didn’t have a license for extraction.
- Paradise Exotics Distro lost its license in July after regulators alleged the company sold products made in California.
Golden Roots was the first alleged rulebreaker in New Mexico to be asked to pay a large fine.
Source: https://mjbizdaily.com/new-mexico-cannabis-operator-fined-loses-license-for-alleged-biotrack-fraud/
Four marijuana companies, including a multistate operator, have filed a lawsuit against U.S. Attorney General Merrick Garland in which they allege the federal MJ prohibition under the Controlled Substances Act is no longer constitutional.
According to the complaint, filed Thursday in U.S. District Court in Massachusetts, retailer Canna Provisions, Treevit delivery service CEO Gyasi Sellers, cultivator Wiseacre Farm and MSO Verano Holdings Corp. are all harmed by “the federal government’s unconstitutional ban on cultivating, manufacturing, distributing, or possessing intrastate marijuana.”
Verano is headquartered in Chicago but has operations in Massachusetts; the other three operators are based in Massachusetts.
The lawsuit seeks a ruling that the “Controlled Substances Act is unconstitutional as applied to the intrastate cultivation, manufacture, possession, and distribution of marijuana pursuant to state law.”
The companies want the case to go before the U.S. Supreme Court.
They hired prominent law firm Boies Schiller Flexner to represent them.
The New York-based firm’s principal is David Boies, whose former clients include Microsoft, former presidential candidate Al Gore and Elizabeth Holmes’ disgraced startup Theranos.
Similar challenges to the federal Controlled Substances Act (CSA) have failed.
One such challenge led to a landmark Supreme Court decision in 2005.
In Gonzalez vs. Raich, the highest court in the United States ruled in a 6-3 decision that the commerce clause of the U.S. Constitution gave Congress the power to outlaw marijuana federally, even though state laws allow the cultivation and sale of cannabis.
In the 18 years since that ruling, 23 states and the District of Columbia have legalized adult-use marijuana and the federal government has allowed a multibillion-dollar cannabis industry to thrive.
Since both Congress and the U.S. Department of Justice, currently headed by Garland, have declined to intervene in state-licensed marijuana markets, the key facts that led to the Supreme Court’s 2005 ruling “no longer apply,” Boies said in a statement Thursday.
“The Supreme Court has since made clear that the federal government lacks the authority to regulate purely intrastate commerce,” Boies said.
“Moreover, the facts on which those precedents are based are no longer true.”
Verano President Darren Weiss said in a statement the company is “prepared to bring this case all the way to the Supreme Court in order to align federal law with how Congress has acted for years.”
While the Biden administration’s push to reschedule marijuana would help solve marijuana operators’ federal tax woes, neither rescheduling nor modest Congressional reforms such as the SAFER Banking Act “solve the fundamental issue,” Weiss added.
“The application of the CSA to lawful state-run cannabis business is an unconstitutional overreach on state sovereignty that has led to decades of harm, failed businesses, lost jobs, and unsafe working conditions.”
Alabama regulators are targeting Dec. 1 to award the first batch of medical cannabis business licenses after the agency’s first two attempts were scrapped because of scoring errors and litigation.
The first licenses will be awarded to individual cultivators, delivery providers, processors, dispensaries and state testing labs, according to the Alabama Medical Cannabis Commission (AMCC).
Then, on Dec. 12, the AMCC will award licenses for vertically integrated operations, a designation set primarily for multistate operators.
Licenses are expected to be handed out 28 days after they have been awarded, so MMJ production could begin in early January, according to the Alabama Daily News.
That means MMJ products could be available for patients around early March, an AMCC spokesperson told the media outlet.
Regulators initially awarded 21 business licenses in June, only to void them after applicants alleged inconsistencies with how the applications were scored.
Then, in August, the state awarded 24 different licenses – 19 went to June recipients – only to reverse themselves again and scratch those licenses after spurned applicants filed lawsuits.
A state judge dismissed a lawsuit filed by Chicago-based MSO Verano Holdings Corp., but another lawsuit is pending.
Source: https://mjbizdaily.com/alabama-plans-to-award-medical-cannabis-licenses-dec-1/
New Mexico cannabis operator fined, loses license for alleged BioTrack fraud
Marijuana companies suing US attorney general in federal prohibition challenge
Alabama to make another attempt Dec. 1 to award medical cannabis licenses
Pot Odor Does Not Justify Probable Cause for Vehicle Searches, Minnesota Court Affirms
New Mexico cannabis operator fined, loses license for alleged BioTrack fraud
Alabama to make another attempt Dec. 1 to award medical cannabis licenses
-
Business1 year agoPot Odor Does Not Justify Probable Cause for Vehicle Searches, Minnesota Court Affirms
-
Business11 months agoNew Mexico cannabis operator fined, loses license for alleged BioTrack fraud
-
Business11 months agoAlabama to make another attempt Dec. 1 to award medical cannabis licenses
-
Business1 year agoWashington State Pays Out $9.4 Million in Refunds Relating to Drug Convictions
-
Business11 months agoMarijuana companies suing US attorney general in federal prohibition challenge
-
Business1 year agoLegal Marijuana Handed A Nothing Burger From NY State
-
Business1 year agoCan Cannabis Help Seasonal Depression
-
Blogs1 year agoCannabis Art Is Flourishing On Etsy